Origins & Effects of BPC-157 | Dr. Abud Bakri & Dr. Andrew Huberman
A ten minute clip in which Dr. Abud Bakri tells Andrew Huberman where BPC-157 came from, what preclinical studies report, and what clinic patients say about it.
With Dr. Andrew Huberman (Dr.), Dr. Abud Bakri (Dr.)
Key moments
Tap a moment to play the video from there.
- 0:00What BPC-157 isBakri says BPC-157 is a 15 amino acid fragment of a large protein called BPC. He says the body makes the large protein, not the fragment.
- 1:32Pavlov and dog gastric juiceBakri describes Pavlov selling dog gastric juice as a remedy for stomach complaints, then Selye's stress findings, as the background for the search for a protective gut compound.
- 3:48The Croatian group's discoveryBakri says the 1991 paper identified the large protein and then the 15 amino acid fragment he says drives the effects. He also mentions that other gut peptides may exist.
- 4:55Preclinical injury and ulcer studiesBakri lists tendon, ligament and burn injury studies in which treated animals reportedly healed faster or avoided gastric ulcers. Huberman says he has seen repair data himself, in animals.
- 5:43Gut origin versus bodybuilder useBakri says the Achilles paper drew bodybuilder interest, although the original idea was a gastric treatment. Huberman notes how unusual it is for one compound to affect tendon, ligament and nerve.
- 6:52Proposed repair mechanismsBakri describes increased VEGF signaling and blood vessel growth, cell migration, and an anti-stress effect when given alongside corticosteroids in preclinical studies.
- 8:00Anti-inflammatory or gas pedalAsked whether it lowers inflammation, Bakri says it acts more like pressing the gas pedal on repair. He cites more growth hormone receptors in one tendon model and nitric oxide modulation.
- 9:08Neurological effects and dopamineBakri describes preclinical alcohol and withdrawal results and patient reports of blunted Adderall and low mood, which he links to dopamine signaling.
What the video says
This clip opens a longer conversation about BPC-157. Andrew Huberman asks Dr. Abud Bakri what it is and what is known about it, and says safety and a consumer and clinician stance will come later. Bakri says BPC-157 is a 15 amino acid piece of a much larger protein, BPC, which he puts at about 40,000 Daltons. He says people make the large protein but not BPC-157 itself, which he describes as a common misunderstanding online.
Most of the first half is history. Bakri traces the idea from Pavlov selling dog gastric juice as a stomach remedy, to Hans Selye's observations of stressed animals (larger adrenals, damaged stomach lining, shrunken thymus), to a Croatian group in 1991 that proposed a protective compound in gut juice. He says that group found the large protein and then the 15 amino acid fragment. He adds that the original aim was a gut treatment, and that bodybuilder interest began after a tendon paper in preclinical studies.
Huberman says he has seen data showing faster repair of tendon, ligament and nerve pathways in animals, and stresses this is not an endorsement. He asks about mechanism. Bakri says it appears to modulate growth and healing pathways: more VEGF signaling and new blood vessel formation, which he says drives much of the safety controversy, plus cell migration, nitric oxide effects, and more growth hormone receptors in one tendon model. He says healing was maintained or improved even when corticosteroids were given, and describes the compound as pressing the gas pedal on repair rather than simply lowering inflammation.
The last section turns to the nervous system. Bakri describes preclinical alcohol and withdrawal experiments and says he finds the neuropsychiatric and gut-brain effects more interesting than the musculoskeletal ones. He reports that some patients say their Adderall works less well while taking oral BPC, and that online forums contain posts about low mood and low energy. He frames this as a sign of dopamine signaling effects. Huberman jokes about the alcohol finding and does not endorse mixing the two.
On each compound
BPC-1570:00
Bakri describes it as a 15 amino acid fragment of a roughly 40,000 Dalton protein first studied by a Croatian group in the 1990s. He discusses preclinical gut, tendon and nerve findings, a proposed role for VEGF signaling, and patient reports of dopamine-related effects. Huberman says he is not endorsing it.
See how your DNA reads BPC-157“We don't naturally make BPC 157.”
What this video doesn’t settle
- The video does not cover human clinical trial evidence, and the repair findings Bakri and Huberman describe come from preclinical studies.
- Safety is only touched on through the VEGF and blood vessel growth controversy, and the clip gives no assessment of risk.
- The reports of blunted Adderall and low mood are patient anecdotes and online posts, with no controls or measurements.
Questions this video answers
What is BPC-157 according to Dr. Abud Bakri?
Bakri says it is a 15 amino acid fragment of a larger protein called BPC, which he puts at about 40,000 Daltons. He says the body makes the large protein but not BPC-157 itself.
Where did BPC-157 come from?
Bakri traces it to research on gastric juice, from Pavlov's dog gastric juice remedy and Hans Selye's stress work to a Croatian group in 1991. He says that group isolated the large protein and then the fragment.
How might BPC-157 work, according to this video?
Bakri says it appears to modulate several growth and healing pathways, including VEGF signaling, cell migration, nitric oxide and growth hormone receptors in one tendon model. Huberman notes it has no known single receptor.
Does BPC-157 affect dopamine or mood?
Bakri says some of his patients report that Adderall works less well while taking oral BPC. He also mentions online posts about low mood and low energy, and links these to dopamine signaling.
Does Huberman endorse BPC-157 in this clip?
No. He says explicitly that his comments are not an endorsement. He also stresses that the repair data he has seen come from animals.
Video by Huberman Lab Clips on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
